The 6th Int'l Conference on Cancer Therapy and Translational Medicine (CTTM 2026)

About

This conference focuses on advancements in cancer therapy and translational medicine, bringing together researchers and professionals to discuss innovative treatments and clinical applications.

Oncologists, researchers, and clinicians from around the world are heading to Kunming, China, for the 6th Int'l Conference on Cancer Therapy and Translational Medicine (CTTM 2026). This healthcare meeting puts the spotlight on how lab discoveries make their way into clinical practice. Sessions will cover immunotherapy, targeted treatments, precision oncology, and drug development. Attendees swap findings on biomarkers, clinical trial design, and patient care strategies that shape modern cancer treatment. Kunming has built a growing reputation as a life sciences hub, which makes it a fitting host city for CTTM 2026. Experts from hospitals, research institutes, and pharmaceutical companies across Asia and beyond will be there. Whether you specialize in translational research, oncology nursing, or medical technology, the conference offers practical insight into turning scientific breakthroughs into real therapies. And if you're a professional tracking cancer therapy and translational medicine in China, CTTM 2026 provides a focused setting to connect, publish, and collaborate.